Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ)
CNY 13.24
(0.68%)
CNY 13.24
(0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.44 Billion | 1.87 Billion | 3.1 Billion | 3.78 Billion | 4.51 Billion | 3.93 Billion |
| Cost of Revenue | 277.5 Million | 243.6 Million | 277.05 Million | 311.44 Million | 336.21 Million | 277.77 Million |
| Gross Profit | 1.16 Billion | 1.62 Billion | 2.82 Billion | 3.47 Billion | 4.18 Billion | 3.65 Billion |
| Operating Expenses | 1.38 Billion | 1.91 Billion | 2.47 Billion | 2.72 Billion | 3.32 Billion | 2.92 Billion |
| Selling, General and Administrative Expenses | 895.81 Million | 1.23 Billion | 2.05 Billion | 2.33 Billion | 2.85 Billion | 2.48 Billion |
| Research and Development Expenses | 472 Million | 588.83 Million | 324.44 Million | 255.89 Million | 310.1 Million | 290.26 Million |
| Other Expenses | - | 82.68 Million | 98.54 Million | 132.5 Million | 157.5 Million | 10.45 Million |
| Cost and Expenses | 1.66 Billion | 2.15 Billion | 2.75 Billion | 3.03 Billion | 3.65 Billion | 3.2 Billion |
| Operating Income | -290.48 Million | -282.44 Million | 402.51 Million | 790.3 Million | 871.99 Million | 744.47 Million |
| Interest Expense | 3.07 Million | 2.76 Million | 3.99 Million | 2.95 Million | 45.95 Thousand | 468.59 Thousand |
| Income Tax Expense | 6.55 Million | 3.7 Million | 25.5 Million | 95.82 Million | 108.03 Million | 86.03 Million |
| Earnings before Tax | -200.92 Million | -262.5 Million | 406.07 Million | 821.19 Million | 887.93 Million | 754.93 Million |
| Net Income | -148.52 Million | -266.2 Million | 379.9 Million | 721.62 Million | 780.95 Million | 670.07 Million |
| Earnings Per Share Basic | -0.16 | -0.29 | 0.41 | 0.78 | 0.84 | 0.89 |
| Earnings Per Share Diluted | -0.16 | -0.29 | 0.41 | 0.78 | 0.84 | 0.89 |
| Weighted Average Shares Outstanding | 928.31 Million | 928.16 Million | 928.16 Million | 928.16 Million | 928.16 Million | 752.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 928.31 Million | 928.16 Million | 928.16 Million | 928.16 Million | 928.16 Million | 752.89 Million |
| Gross Margin | 0.81 | 0.87 | 0.91 | 0.92 | 0.93 | 0.93 |
| EBIT Margin | -0.08 | -0.08 | 0.16 | 0.24 | 0.22 | 0.21 |
| Profit Margin | -0.10 | -0.14 | 0.12 | 0.19 | 0.17 | 0.17 |
| EBITDA | -112.74 Million | -163.56 Million | 498.4 Million | 913.65 Million | 977.08 Million | 838.53 Million |
| Earnings Before Tax Margin | -0.20 | -0.15 | 0.13 | 0.21 | 0.19 | 0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 455.95 Million | 468.37 Million | 448.49 Million | 1.44 Billion | 323.71 Million | 407.89 Million |
| Cost of Revenue | 82.9 Million | 95.27 Million | 81.87 Million | 277.05 Million | 72.01 Million | 66.74 Million |
| Gross Profit | 373.05 Million | 373.09 Million | 366.62 Million | 1.16 Billion | 251.7 Million | 341.15 Million |
| Operating Expenses | 327.33 Million | 350.47 Million | 349.76 Million | 1.42 Billion | 265.88 Million | 386.84 Million |
| Selling, General and Administrative Expenses | 286.38 Million | 294.24 Million | 282.13 Million | - | 145.54 Million | 299.37 Million |
| Research and Development Expenses | 41.64 Million | 55.9 Million | 63.51 Million | - | 57.45 Million | 125.62 Million |
| Other Expenses | 693.58 Thousand | -327.52 Thousand | 996 Thousand | 18.94 Million | 18.84 Million | -267.95 Thousand |
| Cost and Expenses | 410.24 Million | 445.74 Million | 431.63 Million | 1.7 Billion | 337.89 Million | 453.58 Million |
| Operating Income | 45.71 Million | 22.62 Million | 27.8 Million | -219.87 Million | -5.11 Million | -34.56 Million |
| Interest Expense | - | 1.09 Million | 525.56 Thousand | 2.81 Million | 1.26 Million | 131.74 Thousand |
| Income Tax Expense | 8.01 Million | 4.6 Million | 2.36 Million | 6.55 Million | 1.24 Million | 4.27 Million |
| Earnings before Tax | 50.99 Million | 42.48 Million | 28.8 Million | -200.92 Million | 13.73 Million | -34.83 Million |
| Net Income | 51.42 Million | 44.04 Million | 31.54 Million | -148.52 Million | 36.12 Million | -26.2 Million |
| Earnings Per Share Basic | 0.06 | 0.05 | 0.03 | - | 0.04 | -0.03 |
| Earnings Per Share Diluted | 0.06 | 0.05 | 0.03 | - | 0.04 | -0.03 |
| Weighted Average Shares Outstanding | 928.16 Million | 928.16 Million | 1.05 Billion | 928.31 Million | 943.41 Million | 928.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 928.16 Million | 928.16 Million | 1.05 Billion | 928.31 Million | 943.41 Million | 928.16 Million |
| Gross Margin | 0.82 | 0.80 | 0.82 | 0.81 | 0.78 | 0.84 |
| EBIT Margin | 0.11 | 0.10 | 0.06 | - | 0.03 | -0.09 |
| Profit Margin | 0.11 | 0.09 | 0.07 | -0.10 | 0.11 | -0.06 |
| EBITDA | 50.99 Million | 45.6 Million | 24.76 Million | - | 8.31 Million | -37.33 Million |
| Earnings Before Tax Margin | 0.10 | 0.05 | 0.06 | -0.15 | -0.02 | -0.08 |
WILLAMAGOR
3532
HAT
UBQ
AEE
GYANDEV